Low doses of 3-nitropropionic acid in vivo induce damage in mouse skeletal muscle

Neurological Sciences

Volumn 32, Issue 2, 2011, Pages 241-254

  Hernández Echeagaray, Elizabeth ^a   González, Nancy ^a   Ruelas, Angélica ^a   Mendoza, Ernesto ^a   Rodríguez Martínez, Erika ^a   Antuna Bizarro, Rafael ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

Author keywords

3 NP; Muscle; Neurodegeneration; Oxidative phosphorylation; SDH

Indexed keywords

3 NITROPROPIONIC ACID; ACETYLCHOLINESTERASE; ALKALINE PHOSPHATASE; CYTOCHROME C OXIDASE; NITRATE; NITRIC OXIDE; NITRITE; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE (UBIQUINONE);

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL DAMAGE; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME INHIBITION; GASTROCNEMIUS MUSCLE; GRACILIS MUSCLE; IN VIVO STUDY; LIPID PEROXIDATION; MALE; MOTOR DYSFUNCTION; MOUSE; MUSCLE ATROPHY; MUSCLE INJURY; NONHUMAN; OROFACIAL DYSKINESIA; OXIDATIVE STRESS; PROTEIN EXPRESSION; RESPIRATORY CHAIN; SARCOMERE;

ANIMALS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, TRANSMISSION; MUSCLE, SKELETAL; NEUROTOXINS; NITRO COMPOUNDS; PROPIONIC ACIDS;

EID: 79952901959     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-010-0394-2     Document Type: Article

References (52)

1. WAJ Brennan ED Bird JR Aprille 1985 Regional mitochondrial respiratory activity in Huntington's disease brain J Neurochem 44 1948 1950 2985766 10.1111/j.1471-4159.1985.tb07192.x 1:CAS:528:DyaL2MXks12htb4%3D (Pubitemid 15047284)
2. VM Mann JM Cooper F Javoy-Agid Y Agid P Jenner AH Schapira 1990 Mitochondrial function and parental sex in Huntingtons disease Lancet 336 749 1975918 10.1016/0140-6736(90)92242-A 1:STN:280:DyaK3czns1yrtQ%3D%3D (Pubitemid 20309171)
3. MF Beal 2005 Mitochondria take center stage in aging and neurodegeneration Ann Neurol 58 495 505 16178023 10.1002/ana.20624 1:CAS:528:DC%2BD2MXhtFGrs7fE (Pubitemid 41377212)
4. A Benchoua Y Trioulier D Zala MC Gaillard N Lefort N Dufour F Saudou JM Elalouf E Hirsch P Hantraye N Deglon E Brouillet 2006 Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin Mol Biol Cell 17 1652 1663 16452635 10.1091/mbc.E05-07-0607 1:CAS:528:DC%2BD28XltlWjsrw%3D (Pubitemid 44011583)
5. E Brouillet F Conde MF Beal P Hantraye 1999 Replicating Huntington's disease phenotype in experimental animals Prog Neurobiol 59 427 468 10515664 10.1016/S0301-0082(99)00005-2 1:CAS:528:DyaK1MXmsFOhs7c%3D (Pubitemid 29392967)
6. E Brouillet C Jacquard N Bizat D Blum 2005 3-Nitropropionic acid: mitochondrial toxin to uncover physiopathological mechanism underlaying striatal degeneration in Huntingtons disease J Neurochem 95 1521 1540 16300642 10.1111/j.1471-4159.2005.03515.x 1:CAS:528:DC%2BD28XhsVKjtQ%3D%3D (Pubitemid 41804051)
7. JR Zierath JA Hawley 2004 Skeletal muscle fiber type: influence on contractile and metabolic properties PLOS Biol 2 10 337 348 10.1371/journal. pbio.0020348 (Pubitemid 39532910)
8. WR Schabitz K Glatz C Schuhan C Sommer C Berger M Schwaninger M Hartmann H Hilmar Goebel HH Meinck 2003 Severe forward flexion of the trunk in Parkinson's disease: focal myopathy of the paraspinal muscles mimicking camptocormia Mov Disord 18 408 414 12671947 10.1002/mds.10385 (Pubitemid 36531454)
9. JL Bradshaw JG Phillips C Dennis JB Mattingley D Andrewes E Chiu JM Pierson JA Bradshaw 1992 Initiation and execution of movement sequences in those suffering from and at-risk of developing Huntington's disease J Clin Exp Neuropsychol 14 179 192 1533401 10.1080/01688639208402822 1:STN:280: DyaK383kt1Chsg%3D%3D
10. AR Aron L Watkins BJ Sahakian S Monsell RA Barker TW Robbins 2003 Task-set switching deficits in early-stage Huntington's disease: implications for basal ganglia function J Cogn Neurosci 15 629 642 12965037 10.1162/jocn.2003.15.5.629 (Pubitemid 36871877)
11. G Abbruzzese A Berardelli 2003 Sensorimotor integration in movement disorders Mov Disord 18 231 240 12621626 10.1002/mds.10327 (Pubitemid 36410819)
12. AO Robbins AK Ho RA Barker 2006 Weight changes in Huntington's disease Eur J Neurol 13 8 e7 16879284 10.1111/j.1468-1331.2006.01319.x 1:STN:280:DC%2BD28vls1GgtQ%3D%3D (Pubitemid 44124671)
13. K Sathasivam C Hobbs M Turmaine L Mangiarini A Mahal F Bertaux EE Wanker P Doherty SW Davies G Bates 1999 Formation of polyglutamine inclusions in non-CNS tissue Hum Mol Gen 8 813 822 10196370 10.1093/hmg/8.5.813 1:CAS:528:DyaK1MXivFamsbc%3D (Pubitemid 29189048)
14. RR Ribchester D Thomson NI Wood T Hinks TH Gillingwater TM Wishart FA Court AJ Morton 2004 Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutation Eur J Neurosci 20 3092 3114 15579164 10.1111/j.1460-9568.2004.03783.x (Pubitemid 40007304)
15. N Stoy E McKay 2000 Weight loss in Huntington's disease Ann Neurol 48 130 131 10894233 10.1002/1531-8249(200007)48:1<130::AID-ANA27>3.0.CO;2-8 1:STN:280:DC%2BD3czltVOgsw%3D%3D
16. JA Simoneau SR Colberg FL Thaete DE Kelley 1995 Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women FASEB J 9 273 278 7781930 1:CAS:528:DyaK2MXjvFKjur4%3D
17. KF Petersen S Durour D Befroy R García GI Shulman 2004 Impaired mitochondrial activity in the insuline resistant offspring of patients with type 2 diabetes N Engl J Med 350 664 671 14960743 10.1056/NEJMoa031314 1:CAS:528:DC%2BD2cXhtFCrtrc%3D (Pubitemid 38364625)
18. MF Beal E Brouillet BG Jenkins RJ Ferrante NW Kowall JM Miller E Storey R Srivastava BR Rosen BT Hyman 1993 Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid J Neurosci 13 4181 4192 7692009 1:CAS:528: DyaK3sXms1CgtLc%3D (Pubitemid 23299942)
19. CV Borlongan H Nishino PR Sanberg 1997 Systemic but not intraparenquimal administration of 3-nitropropionic acid mimics the neuropathology of Huntington's disease: a speculative explanation Neurosci Res 28 185 189 9237266 10.1016/S0168-0102(97)00045-X 1:CAS:528:DyaK2sXkslertLk%3D (Pubitemid 27280918)
20. T Alexi PE Hughes B Knüsel AT Tobin 1998 Metabolic compromise with systemic 3-Nitropropionic acid produces striatal apoptosis in Sprague-Dawley rats but no in BALB/c ByJ mice Exp Neurol 153 74 93 9743569 10.1006/exnr.1998. 6842 1:CAS:528:DyaK1cXmvVWgsbw%3D (Pubitemid 28452299)
21. KL Gabrielson BA Hogue VA Bohr AJ Cardounel W Nakajima J Kofler JL Zweier ER Rodriguez LJ Martin NC de Souza Pinto J Bressier 2001 Mitochondrial toxin 3-Nitropropionic acid induces cardiac and neurotoxicity differentially in mice Am J Pathol 159 1507 1520 11583977 10.1016/S0002-9440(10)62536-9 1:CAS:528:DC%2BD3MXnvVCmsL4%3D (Pubitemid 32947979)
22. A Mansouri FL Muller Y Liu R Ng J Faulkner M Hamilton A Richardson TT Huang CJ Epstein H Van Remmen 2006 Alterations in mitochondrial function, hydrogen peroxide release and oxidative damage in mouse hind-limb skeletal muscle during aging Mech Ageing Dev 127 298 306 16405961 10.1016/j.mad.2005.11. 004 1:CAS:528:DC%2BD28XhtlCqtb8%3D (Pubitemid 43214503)
23. RJ Mailloux R Beriault J Lemire R Singh DR Chenier RD Hamel VD Appanna 2007 The tricarboxylic acid cycle, an ancient metabolic network with a novel twist PLoS ONE 2 1 e690 17668068 10.1371/journal.pone.0000690 (Pubitemid 351325409)
24. Hildebrand M, Goslow GE Jr (2002) Muscles and electric organs. In: Analysis of vertebrate structure, 5th edn. John Wiley & Sons Inc, New York, pp 169-178
25. SC Leary CN Lyons AG Rosenberger JS Ballantyne J Stillman CD Moyes 2003 Fibre-type differences in muscle mitochondrial profiles Am J Physiol Regul Integr Comp Physiol 285 817 826
26. D Deveci JM Marshall S Egginton 2001 Relationship between capillary angiogenesis, fibre type, and fibre size in chronic systemic hypoxia Am J Physiol Heart Circ Physiol 281 241 252
27. JB Schulz RT Matthews BG Jenkins RJ Ferrante D Siwek DR Henshaw PB Cipolloni P Mecocci NW Kowall BR Rosen MF Beal 1995 Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo J Neurosci 15 8419 8429 8613773 1:CAS:528:DyaK28Xls12q (Pubitemid 26009682)
28. R Bassel-Duby EN Olson 2006 Signaling pathways in skeletal muscle remodeling Annu Rev Biochem 75 19 37 16756483 10.1146/annurev.biochem.75.103004. 142622 1:CAS:528:DC%2BD28XosVKhsr8%3D (Pubitemid 44118024)
29. MTT Wong-Riley 1989 Cytochrome oxidase: an endogenous metabolic marker for neuronal activity TINS 12 94 101 2469224 1:CAS:528:DyaL1MXitV2lurc%3D (Pubitemid 19067056)
30. S Di Mauro K Tanji E Binilla F Pallotti EA Schon 2002 Mitochondrial abnormalities in muscle and other aging cells: classification, causes and effects Muscle Nerve 26 597 607 10.1002/mus.10194 1:CAS:528:DC%2BD38XovFKjsb0%3D (Pubitemid 35266083)
31. FM Hansen-Smith L Watson GR Joswiak 1989 Postnatal changes in capillary density of rat sternomastoid muscle Am J Physiol 257 344 347
32. A Wagatsuma H Tamaki F Ogita 2005 Capillary supply and gene expression of angiogenesis-related factors in murine skeletal muscle following denervation Exp Physiol 90 403 409 15708874 10.1113/expphysiol.2004.029769 1:CAS:528:DC%2BD2MXltVWrs7s%3D (Pubitemid 40685854)
33. P Oettgen 2006 Transcriptional regulation of vascular development Cir Res 89 380 388 10.1161/hh1701.095958 (Pubitemid 34132653)
34. S Egginton O Hudlicka 2000 Selective long-term electrical stimulation of fast glycolytic fibres increases capillary supply but not oxidative enzyme activity in rat skeletal muscles Exp Physiol 85 567 573 11038408 10.1017/S0958067000020285 1:STN:280:DC%2BD3M%2FisFKrsg%3D%3D
35. I Fuentes AR Cobos LAG Segade 1998 Muscle fibre types and their distribution in the biceps and triceps branchii of the rat and rabbit J Anat 192 203 210 9643421 10.1046/j.1469-7580.1998.19220203.x (Pubitemid 28241227)
36. WK Ovalle PR Dow PC Nahirney 1999 Structure and distribution and innervation of muscle spindles in avian fast and slow skeletal muscle J Anat 194 381 394 10386776 10.1046/j.1469-7580.1999.19430381.x (Pubitemid 29241490)
37. MW Riepe AC Ludolph 1997 Chemical preconditioning a cytoprotective strategy Mol Cell Biochem 174 249 254 9309696 10.1023/A:1006820927262 1:CAS:528:DyaK2sXmt1equ74%3D (Pubitemid 27404199)
38. K Aure G Fayet JP Leroy E Lacene NB Romero A Lombes 2006 Apoptosis in mitochondrial myopathies is linked to mitochondrial proliferation Brain 129 1249 1259 16537564 10.1093/brain/awl061
39. E Bossy-Wetzel MJ Barsoum A Godzik R Schwarzenbacher SA Lipton 2003 Mitochondrial fission in apoptosis, neurodegeneration and aging Cur Op Cell Biol 15 706 716 10.1016/j.ceb.2003.10.015 1:CAS:528:DC%2BD3sXptlyks7o%3D (Pubitemid 37487964)
40. MJ Barsoum H Yuan AA Gerencser G Liot Y Kushnareva S Graber I Kovacs WD Lee J Waggoner J Cui AD White B Bossy JC Martinou RJ Youle SA Lipton MH Ellisman GA Perkins E Bossy-Wetzel 2006 Nitric oxide induced mitochondrial fission is regulated by Dynamin related GTPases in neurons EMBO J 25 3900 3911 16874299 10.1038/sj.emboj.7601253 1:CAS:528:DC%2BD28XovVSqurc%3D (Pubitemid 44300275)
41. JM Barral HF Epstein 1999 Protein machines and self assembly in muscle organization Bioessays 21 813 823 10497331 10.1002/(SICI)1521-1878(199910)21: 10<813::AID-BIES3>3.0.CO;2-0 1:STN:280:DyaK1MvivVakuw%3D%3D (Pubitemid 29475489)
42. KA Clark AS Mc Elhinny MC Beckerle CC Gregorio 2002 Striated muscle cytoarchitecture: an intricate web of form and function Ann Rev Cell Dev Biol 18 637 706 10.1146/annurev.cellbio.18.012502.105840 1:CAS:528:DC%2BD38XptVOqs7s%3D (Pubitemid 35387364)
43. WMJ Obermann M Gautel F Steiner PFM van der Ven K Weber DO Fürst 1996 The structure of the sarcomeric M Band: Localization of defined domains of myomesin, M-protein, and the 250-kD carboxy-terminal region of titin by immunoelectron microscopy J Cell Biol 134 1441 1453 8830773 10.1083/jcb.134.6. 1441 1:CAS:528:DyaK28Xls1yktL0%3D (Pubitemid 26318017)
44. Carpenter S, Karpati G. Pathology of skeletal muscle (2002) Churchill Livingstone; London, pp. 634-635
45. RJ Carter LA Lione T Humby L Mangiarini A Mahal GP Bates SB Dunnett AJ Morton 1999 Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation J Neurosci 19 3248 3257 10191337 1:CAS:528:DyaK1MXitlGmsro%3D (Pubitemid 29174016)
46. KP Murphy RJ Carter LA Lione L Mangiarini A Mahal GP Bates SB Dunnett AJ Morton 2000 Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation J Neurosci 20 5115 5123 10864968 1:CAS:528:DC%2BD3cXksF2jtL8%3D (Pubitemid 30421714)
47. MA Hickey MF Chesselet 2003 The use of transgenic and knock-in mice to study Huntington's disease Cytogenet Genome Res 100 276 286 14526189 10.1159/000072863 1:CAS:528:DC%2BD3sXnslarsLY%3D (Pubitemid 37467815)
48. AE Zaninovich 2005 Role of uncoupling proteins UCP1, UCP2 and UCP3 in energy balance, type 2 diabetes and obesity: synergism with the thyroid Medicina 65 163 169 16075814 1:CAS:528:DC%2BD2MXlvFWhtrg%3D
49. F Mochel P Charles F Seguin S Barritaul C Coussieu PerinL Le Y Bouc C Gervais G Carcelain A Vassault J Feingold D Rabier A Durr 2007 Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression PLoS ONE 7 e647 10.1371/journal.pone.0000647 (Pubitemid 351314890)
50. M Ristow 2004 Neurodegenerative disorders associated with diabetes mellitus J Mol Med 82 510 529 15175861 10.1007/s00109-004-0552-1 (Pubitemid 39149861)
51. SM Woodall BH Breier BM Johnston PD Gluckman 1996 A model of intrauterine growth retardation caused by chronic maternal undernutrition in the rat: effects on the somatotrophic axis and postnatal growth J Endocrinol 150 231 242 8869590 10.1677/joe.0.1500231 1:CAS:528:DyaK28XltlSns7s%3D (Pubitemid 26295618)
52. JC Clapham 2004 Treating obesity: pharmacology of energy expenditure Cur Drug Targets 5 309 332 10.2174/1389450043490451 1:CAS:528:DC%2BD2cXisFKjsLk%3D (Pubitemid 38372315)